SCOTT MOFFITT: Open Payments
NPI 1881169043 · SANDY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 54 payments from 10 companies in 2025. Trend: 2023 $697 · 2024 $882 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $364 |
| ABBVIE INC. | 22 | $327 |
| GENZYME CORPORATION | 4 | $83 |
| PFIZER INC. | 3 | $48 |
| Ardelyx, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| ORPHALAN INC | 1 | $28 |
| Celltrion USA Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: TREMFYA, RINVOQ, CREON, DUPIXENT, SKYRIZI, XELJANZ, IBSRELA, ENTYVIO.
Industry payments across UT — which companies pay providers there.
